|
|
Volumn 99, Issue 13, 2007, Pages
|
|
Targeting vessel abnormalization in cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
DLL4 PROTEIN, HUMAN;
SIGNAL PEPTIDE;
UNCLASSIFIED DRUG;
ANIMAL;
ARTICLE;
CELL LINEAGE;
DRUG DESIGN;
HUMAN;
METABOLISM;
NEOPLASM;
NEOVASCULARIZATION (PATHOLOGY);
PATHOLOGY;
PHARMACEUTICS;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINEAGE;
DRUG DESIGN;
HUMANS;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 34447282826
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djm056 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
